Animal Pharm Podcast #24: Elanco's Aaron Schacht talks innovation, pipeline and partners
At the recent Animal Health Investment Europe conference in London, Animal Pharm editor Joseph Harvey caught up with Elanco's Aaron Schacht. The podcast below covers a range of topics linked to Elanco's take on innovation.
Mr Schacht is the company's executive vice president of R&D, regulatory and business development. His purview features Elanco's internal innovation, as well as its hunt for new external collaborations.
In the podcast, Mr Schacht talks about how Elanco's scope for innovation changed after it left Eli Lilly. He also speaks about how the company is becoming more involved in funding some of animal health's brightest new ideas.
If you have any trouble listening to this podcast, try this link.